Norepinephrine transporter blocker atomoxetine increases salivary alpha amylase

Psychoneuroendocrinology

Volumn 78, Issue , 2017, Pages 233-236

  Warren, Christopher M ^a,e   van den Brink, Ruud L ^a   Nieuwenhuis, Sander ^a   Bosch, Jos A ^b,c,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e BOWDOIN COLLEGE   (United States)

Author keywords

Alpha amylase; Atomoxetine; Locus coeruleus; Noradrenaline; Noradrenergic; Sympathetic; Yohimbine

Indexed keywords

ALPHA AMYLASE SALIVA ISOENZYME; ATOMOXETINE; HYDROCORTISONE; NORADRENALIN; NORADRENALIN TRANSPORTER; PLACEBO; ADRENERGIC RECEPTOR AFFECTING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NON INVASIVE PROCEDURE; NORADRENALIN BRAIN LEVEL; NORMAL HUMAN; PARASYMPATHETIC FUNCTION; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SALIVATION; SINGLE DRUG DOSE; CHEMISTRY; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; SALIVA; YOUNG ADULT;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ATOMOXETINE HYDROCHLORIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SALIVA; SALIVARY ALPHA-AMYLASES; YOUNG ADULT;

EID: 85013309471     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2017.01.029     Document Type: Article

References (19)

1. Bagheri, H., Schmitt, L., Berlan, M., Montastruc, J.L., A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur. J. Clin. Pharmacol. 52:5 (1997), 339–342.
2. Beltzer, E.K., Fortunato, C.K., Guaderrama, M.M., Peckins, M.K., Garramone, B.M., Granger, D.A., Salivary flow and alpha-amylase: collection technique, duration, and oral fluid type. Physiol. Behav. 101:2 (2010), 289–296.
3. Berntson, G.G., Cacioppo, J.T., Bosch, J.A., From homeostasis to allodynamic regulation. Cacioppo, J.T., Berntson, G.G., Tassinary, L.G., (eds.) Handbook of Psychophysiology, 4th edition, 2016, Cambridge University Press, Cambridge, 379–400.
4. Berridge, C.W., Waterhouse, B.D., The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Rev. 42:1 (2003), 33–84.
5. Bosch, J.A., de Geus, E.J., Carroll, D., Goedhart, A.D., Anane, L.A., van Zanten, J.J.V., Helmerhorst, E.J., Edwards, K.M., A general enhancement of autonomic and cortisol responses during social evaluative threat. Psychosom. Med. 71:8 (2009), 877–885.
6. Bosch, J.A., Veerman, E.C., de Geus, E.J., Proctor, G.B., α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!. Psychoneuroendocrinology 36:4 (2011), 449–453.
7. Bymaster, F.P., Katner, J.S., Nelson, D.L., Hemrick-Luecke, S.K., Threlkeld, P.G., Heiligenstein, J.H., Morin, S.M., Donald, M.S., Gehlert, D.R., Perry, K.W., Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:5 (2002), 699–711.
8. Chamberlain, S.R., Muller, U., Cleary, S., Robbins, T.W., Sahakian, B.J., Atomoxetine increases salivary cortisol in healthy volunteers. J. Psychopharmacol. (Oxf.) 21 (2007), 545–549.
9. Ditzen, B., Ehlert, U., Nater, U.M., Associations between salivary alpha-amylase and catecholamines—a multilevel modeling approach. Biol. Psychol. 103 (2014), 15–18.
10. Dunn, A.J., Swiergiel, A.H., Palamarchouk, V., Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann. N. Y. Acad. Sci. 1018:1 (2004), 25–34.
11. Ehlert, U., Erni, K., Hebisch, G., Nater, U., Salivary α-amylase levels after yohimbine challenge in healthy men. J. Clin. Endocrinol. Metab. 91:12 (2006), 5130–5133.
12. Hill, S.A., Taylor, M.J., Harmer, C.J., Acute reboxetine administration increases plasma and salivary cortisol. J. Psychopharmacol. 17:3 (2003), 273–275.
13. Nagy, T., van Lien, R., Willemsen, G., Proctor, G., Efting, M., Fülöp, M., Bárdosf, G., Veerman, E.C.I., Bosch, J.A., A fluid response: Alpha-amylase reactions to acute laboratory stress are related to sample timing and saliva flow rate. Biol. Psychol. 109 (2015), 111–119.
14. Proctor, G.B., Carpenter, G.H., Neural control of salivary S-1gA secretion. Int. Rev. Neurobiol. 52 (2002), 187–212.
15. Proctor, G.B., Carpenter, G.H., Regulation of salivary gland function by autonomic nerves. Auton. Neurosci. 133:1 (2007), 3–18.
16. Samuels, E.R., Szabadi, E., Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr. Neuropharmacol. 6:3 (2008), 254–285.
17. Sauer, J.M., Ring, B.J., Witcher, J.W., Clinical pharmacokinetics of atomoxetine. Clin. Pharmacokinet. 44:6 (2005), 571–590.
18. Warren, C.M., Eldar, E., van den Brink, R.L., Tona, K.D., van der Wee, N.J., Giltay, E.J., van Noorden, M.S., Bosch, J.A., Wilson, R.C., Cohen, J.D., Nieuwenhuis, S., Catecholamine-mediated increases in neural gain improve the precision of cortical representations?. J. Neurosci. 36:21 (2016), 5699–5708.
19. van den Brink, R.L., Pfeffer, T., Warren, C.M., Murphy, P.R., Tona, K.D., van der Wee, N.J., Giltay, E.J., van Noorden, M.S., Rombouts, S.A., Donner, T.H., Nieuwenhuis, S., Catecholaminergic neuromodulation shapes intrinsic MRI functional connectivity in the human brain. J. Neurosci. 36:30 (2016), 7865–7876.